価格表
在庫・価格 : 2025年05月02日 03時41分 現在
商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
---|---|---|---|---|---|---|
Anti-LRRK2, Rabbit-Poly <Anti-Leucine-Rich Repeat Kinase 2> データシート※最新のデータシートでない場合があります |
NB300-268SS |
NOVノバス バイオロジカルス Novus biologicals, LLC |
0.025 ml | ¥48,000 |
無 (未発注) |
追加 |
在庫・価格 : 2025年05月02日 03時41分 現在
Anti-LRRK2, Rabbit-Poly <Anti-Leucine-Rich Repeat Kinase 2>
- 商品コード:NB300-268SS
- メーカー:NOV
- 包装:0.025ml
- 価格: ¥48,000
- 在庫:無(未発注)
使用文献
- No.: 1
-
文献情報:
Miklossy J et al. LRRK2 expression in normal and pathologic human brain and in human cell lines. J. Neuropathol. Exp. Neurol. 2006 Oct;65(10):953-63
Miklossy J et al
2006/01/01
-
備考:
-
参照:
- No.: 2
-
文献情報:
Melrose HL et al. A comparative analysis of leucine-rich repeat kinase 2 (Lrrk2) expression in mouse brain and Lewy body disease. Neuroscience 2007 Jul;147(4):1047-58
Melrose HL et al
2007/01/01
-
備考:
Western Blot, Immunohistochemistry -
参照:
- No.: 3
-
文献情報:
Hakimi M et al. Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures. J Neural Transm 2011 May;118(5):795-808
Hakimi M et al
2011/01/01
-
備考:
Species: Human, Mouse, Applications: WB -
参照:
- No.: 4
-
文献情報:
Alegre-Abarrategui J et al. LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. Hum. Mol. Genet. 2009 Nov;18(21):4022-34
Alegre-Abarrategui J et al
2009/01/01
-
備考:
Species: Human, Applications: ICC/IF, WB -
参照:
- No.: 5
-
文献情報:
Sekigawa A et al. Distinct mechanisms of axonal globule formation in mice expressing human wild type α-synuclein or dementia with Lewy bodies-linked P123H β-synuclein. Mol Brain 2012;5:34
Sekigawa A et al
2012/01/01
-
備考:
Species: Mouse, Applications: IHC-Fr -
参照:
- No.: 6
-
文献情報:
Venderova K et al. Leucine-Rich Repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease. Hum. Mol. Genet. 2009 Nov;18(22):4390-404
Venderova K et al
2009/01/01
-
備考:
Species: Human, Applications: WB -
参照:
- No.: 7
-
文献情報:
Yao C et al. LRRK2-mediated neurodegeneration and dysfunction of dopaminergic neurons in a Caenorhabditis elegans model of Parkinson's disease. Neurobiol. Dis. 2010 Oct;40(1):73-81
Yao C et al
2010/01/01
-
備考:
Species: C. elegans, Applications: IHC, ICC/IF, WB -
参照:
- No.: 8
-
文献情報:
Pandey N et al. Sequences Located within the N-Terminus of the PD-Linked LRRK2 Lead to Increased Aggregation and Attenuation of 6-Hydroxydopamine-Induced Cell Death. PLoS ONE 2012;7(9):e45149
Pandey N et al
2012/01/01
-
備考:
Species: Human, Applications: WB -
参照:
- No.: 9
-
文献情報:
Greggio E et al. Mutations in LRRK2/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1. J. Neurochem. 2007 Jul;102(1):93-102
Greggio E et al
2007/01/01
-
備考:
Species: Human, Applications: WB -
参照:
- No.: 10
-
文献情報:
Kamikawaji S et al. Differential effects of familial parkinson mutations in LRRK2 revealed by a systematic analysis of autophosphorylation. Biochemistry 2013 Sep;52(35):6052-62
Kamikawaji S et al
2013/01/01
-
備考:
Species: Human, Applications: WB -
参照:
- No.: 11
-
文献情報:
Angeles DC et al. Thiol peroxidases ameliorate LRRK2 mutant-induced mitochondrial and dopaminergic neuronal degeneration in Drosophila. Hum. Mol. Genet. 2014 Jun;23(12):3157-65
Angeles DC et al
2014/01/01
-
備考:
Species: Human, Applications: WB -
参照:
- No.: 12
-
文献情報:
Marker DF et al. LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein. J Neuroinflammation 2012;9:261
Marker DF et al
2012/01/01
-
備考:
Species: Mouse, Applications: ICC/IF -
参照:
- No.: 13
-
文献情報:
Liu Z et al. The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat. Immunol. 2011 Nov;12(11):1063-70
Liu Z et al
2011/01/01
-
備考:
Applications: -
参照:
- No.: 14
-
文献情報:
Saha S et al. LRRK2 modulates vulnerability to mitochondrial dysfunction in Caenorhabditis elegans. J. Neurosci. 2009 Jul;29(29):9210-8
Saha S et al
2009/01/01
-
備考:
Species: C. elegans, Applications: WB -
参照:
- No.: 15
-
文献情報:
Qing H et al. Lrrk2 interaction with alpha-synuclein in diffuse Lewy body disease. Biochem. Biophys. Res. Commun. 2009 Dec;390(4):1229-34
Qing H et al
2009/01/01
-
備考:
Species: Human, Applications: IHC, ICC/IF -
参照:
- No.: 16
-
文献情報:
Ito G et al. Re-examination of the dimerization state of leucine-rich repeat kinase 2: predominance of the monomeric form. Biochem. J. 2012 Feb;441(3):987-94
Ito G et al
2012/01/01
-
備考:
-
参照:
- No.: 17
-
文献情報:
Hatano T et al. Leucine-rich repeat kinase 2 associates with lipid rafts. Hum. Mol. Genet. 2007 Mar;16(6):678-90
Hatano T et al
2007/01/01
-
備考:
Species: Mouse, Applications: WB -
参照:
- No.: 18
-
文献情報:
Kamikawaji S et al. Identification of the autophosphorylation sites of LRRK2. Biochemistry 2009 Nov;48(46):10963-75
Kamikawaji S et al
2009/01/01
-
備考:
Species: Human, Moth, Applications: IP, WB -
参照: